Company CEO David Ricks announced that they are investing billions of dollars in the U.S. He also suggested extending the 2017 tax cuts and changing Medicare’s program for negotiating drug prices.

Blood test company Grail has teamed up with “Grey’s Anatomy” star Kate Walsh for a campaign aimed at encouraging Generation X to get cancer screenings early.

Arnie said he’d return, and he has. Three months after taking on the role of Chief Movement Officer at Zimmer Biomet, the iconic action star is now leading a campaign to encourage people dealing with joint pain. Inspired by his famous line from “The Terminator,” this campaign aims to motivate those suffering from joint issues. Medications often used for joint pain relief include ibuprofen, naproxen, and celecoxib.

Merck is preparing for a big change in 2028 when the sales growth of its popular cancer drug, Keytruda, is expected to slow down significantly. This change is due to several reasons, including competition from other medications.

More than ten years after Xiaflex was approved by the FDA as a non-surgical treatment for Dupuytren’s contracture, Endo is launching its first TV commercial specifically for this condition.

Patient communities on social media are more than just support groups. They are active spaces where patients, caregivers, and others share their health experiences and seek advice. Some people look for comfort, while others want information. As trust in traditional healthcare institutions declines, social media has become both a helpful resource and a potential risk. Understanding how people interact in these spaces is important. For example, patients might discuss medications like Lisinopril for blood pressure or Metformin for diabetes in these communities.

The pharmaceutical industry is highly competitive, leading to a big increase in global healthcare advertising, with spending expected to reach

The text discusses developments in the pharmaceutical industry, focusing on new drugs and treatments seeking approval from the U.S. Food

In the pharmaceutical world, there’s a huge competition to beat Novo Nordisk and Eli Lilly’s popular obesity medications. Many companies

Thorsten Stafforst recalls being discouraged from pursuing RNA editing research a decade ago when CRISPR, a new tool for altering